Specialty Testing and Translational Lab Testing At MLM Medical Labs, our scientists excel in collaboratively designing customized solutions to translate your specific research goals into practical therapeutic applications. We provide expert biomarker identification and validation, comprehensive assay development, tech transfer and validation, regulatory guidance, and project management to advance your novel therapeutics through every phase of the […]

Preclincal Model Development Fibrosis Models Overview Idiopathic pulmonary fibrosis MASH/NASH Systemic Sclerosis New Model Development Further in vivo models Interested in a new model or variation of an existing model? Creating a new preclinical model is a meticulous process that involves innovative scientific approaches. As an established preclinical CRO, we specialize in developing cutting-edge models

Fibrosis Models – IPF Fibrosis Models Overview Idiopathic pulmonary fibrosis MASH/NASH Systemic Sclerosis New Model Development Further in vivo models Bleomycin-induced Idiopathic Pulmonary Fibrosis (IPF) MLM Medical Labs offers an advanced Bleomycin-induced Lung Fibrosis model, established for over a decade in basic research on pulmonary fibrosis. Our methodology employs refined oral aspiration administration, facilitating uniform

Fibrosis Models Fibrosis Models Overview Idiopathic pulmonary fibrosis MASH / NASH Systemic Sclerosis New Model Development Further in vivo models Welcome to MLM Medical Labs, your premier partner for unraveling the complexities of fibrosis and its critical implications for various medical conditions. Fibrosis, characterized by excessive tissue scarring and stiffening, is a hallmark feature in

Fibrosis Model – NASH / MASH Fibrosis Models Overview Idiopathic pulmonary fibrosis MASH / NASH Systemic Sclerosis New Model Development Further in vivo models Accelerating MASH / NASH Drug Discovery with Reliable Preclinical Models Metabolic Dysfunction-associated Steatohepatitis (MASH) Developing effective therapies for metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) presents major challenges—lack of reliable preclinical models,

fibrosis Model – Systemic Sclerosis Fibrosis Models Overview Idiopathic pulmonary fibrosis MASH/NASH Systemic Sclerosis New Model Development Further in vivo models Systemic Sclerosis Systemic Sclerosis (SSc or Scleroderma) stands as a complex autoimmune disease distinguished by vasculopathy, skin and internal organ fibrosis, inflammation, and overarching immune system irregularities. At MLM Medical Labs, our exploration into

Your single source for High-Quality Histopathology services Routine and specialized histology services to support your research and drug development goals At MLM Medical Labs we are committed to providing you with exceptional histopathology services. Our experienced team of scientists are experts in routine and advanced laboratory techniques including tissue processing, sample embedding, IHC assay development,

POINT OF COLLECTION Sample TRACKING True End-to-End Sample Management Clinical trial sponsors have been asking for years to have visibility into where their samples are, especially during the first mile of the sample journey: at the clinical sites.   MLM has partnered with TruLab® to solve for this critical need.  Combining TruLab® technology with our advanced